CD4 and infection: Table 3 compares clinicallyrelevant results (i.e. proxies for disease progression) of the two distinct ARTscenarios, including (1) initiation at CD4 <350 and 80 percent coverage (theART scenario for the primary model comparisons described in Eaton et al. 2012), and (2)initiation at 3 years after infection (also with 80 percent coverage).